Minke, J M <br/><br/>
Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.  [electronic resource] 

 -  Veterinary immunology and immunopathology  May 2006 
 - 47-57 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0165-2427 
<br/><br/><label>Standard No.: </label>10.1016/j.vetimm.2006.01.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--pharmacology<br/>Animals<br/>Antibodies, Viral--blood<br/>Female<br/>Herpesviridae Infections--immunology<br/>Herpesvirus 1, Equid--genetics<br/>Herpesvirus Vaccines--genetics<br/>Horse Diseases--immunology<br/>Horses<br/>Male<br/>Neutralization Tests--veterinary<br/>Polymerase Chain Reaction--veterinary<br/>Statistics, Nonparametric<br/>Vaccination--methods<br/>Vaccines, DNA--immunology<br/>Viral Envelope Proteins--genetics<br/>Viral Vaccines--genetics